SCHEMBL2590236

SCHEMBL2590236

CC1CCN(C(=O)c2cccc(N3CCC(c4ccc(Cl)cc4)CC3)n2)CC1

nearest known ligand 0.53

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 4/20 0.53
TRPC3 Q13507 3/20 0.47
TRPC6 Q9Y210 3/20 0.47
SMN1; SMN2 Q16637 2/20 0.46
FASN P49327 1/20 0.43
GRM5 P41594 1/20 0.41
CCR1 P32246 5/20 0.41
KCNH2 Q12809 1/20 0.41
ACHE P22303 1/20 0.40
KMT2A Q03164 1/20 0.40
PROKR1 Q8TCW9 1/20 0.40
ALDH1A1 P00352 1/20 0.40
LMNA P02545 1/20 0.40
MAPT P10636 1/20 0.40
HPGD P15428 1/20 0.40
IDO1 P14902 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2591221 0.89 HSD11B1 (0.48) HSD11B1TRPC6SMN1; SMN2CCR1ACHE
SCHEMBL2593449 0.87 TRPC6 (0.50) HSD11B1TRPC3TRPC6FASNLMNA
SCHEMBL2593742 0.87 HSD11B1 (0.58) HSD11B1TRPC3TRPC6SMN1; SMN2ACHE
SCHEMBL12183553 0.87 HSD11B1 (0.55) HSD11B1TRPC3TRPC6SMN1; SMN2KMT2A
SCHEMBL2591255 0.81 HSD11B1 (0.56) HSD11B1TRPC3TRPC6SMN1; SMN2ACHE
SCHEMBL12753327 0.77 HSD11B1 (0.69) HSD11B1TRPC3TRPC6SMN1; SMN2GRM5
SCHEMBL15188020 0.76 HSD11B1 (0.50) HSD11B1TRPC3TRPC6SMN1; SMN2ACHE
SCHEMBL12751750 0.76 HSD11B1 (0.67) HSD11B1TRPC3TRPC6SMN1; SMN2ACHE
SCHEMBL27914108 0.76 PRKCQ (0.53) HSD11B1KMT2AMAPT
SCHEMBL2593371 0.76 HSD11B1 (0.47) HSD11B1SMN1; SMN2GRM5KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130210811-A1 PICOLINAMIDE AND PYRIMIDINE-4-CARBOXAMIDE COMPOUNDS, PROCESS FOR PREPARING AND PHAMACEUTICAL COMPOSITION COMPRISING THE SAME SK CHEMICALS CO., LTD. (KR) 2013-08-15 US claimed
EP-2566859-A2 PICOLINAMIDE AND PYRIMIDINE-4-CARBOXAMIDE COMPOUNDS, PROCESS FOR PREPARING AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME Sk Chemicals Co., Ltd. (KR) 2013-03-13 EP claimed
WO-2011139107-A2 PICOLINAMIDE AND PYRIMIDINE-4-CARBOXAMIDE COMPOUNDS, PROCESS FOR PREPARING AND PHAMACEUTICAL COMPOSITION COMPRISING THE SAME SK CHEMICALS CO.,LTD. (KR) 2011-11-10 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130210811-A1 PICOLINAMIDE AND PYRIMIDINE-4-CARBOXAMIDE COMPOUNDS, PROCESS FOR PREPARING AND PHAMACEUTICAL COMPOSITION COMPRISING THE SAME HSD11B1, HSD11B2, G6PC1 HSD11B1 1/4885TRPC3 4165/4885TRPC6 4676/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.